|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CANCER STEM CELLS |
aMaxine Dunitz Neurosurgical Institute, Los Angeles, California, USA;
bDepartment of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA
Key Words. Spheres • Monolayer • Mitogens • Cancer stem-like cells • Glioma
Correspondence: John S. Yu, M.D., 8631 West Third Street, Suite 800E, Los Angeles, California 90048, USA. Telephone: 310-423-0845; Fax: 310-423-0810; e-mail: Yuj{at}cshs.org
Received on October 2, 2006;
accepted for publication on March 29, 2007.
Disclosure of potential conflicts of interest is found at the end of this article.
First published online in STEM CELLS EXPRESS April 5, 2007.
The rat 9L gliosarcoma is a widely used syngeneic rat brain tumor model that closely simulates glioblastoma multiforme when implanted in vivo. In this study, we sought to isolate and characterize a subgroup of cancer stem-like cells (CSLCs) from the 9L gliosarcoma cell line, which may represent the tumor-initiating subpopulation of cells. We demonstrate that these CSLCs form clonal-derived spheres in media devoid of serum supplemented with the mitogens epidermal growth factor and basic fibroblast growth factor, express the NSC markers Nestin and Sox2, self-renew, and differentiate into neuron-like and glial cells in vitro. More importantly, these cells can propagate and recapitulate tumors when implanted into the brain of syngeneic Fisher rats, and they display a more aggressive course compared with 9L gliosarcoma cells grown in monolayer cultures devoid of mitogens. Furthermore, we compare the chemosensitivity and proliferation rate of 9L gliosarcoma cells grown as a monolayer to those of cells grown as floating spheres and show that the sphere-generated cells have a lower proliferation rate, are more chemoresistant, and express several antiapoptosis and drug-related genes, which may prove to have important clinical implications.
This article has been cited by other articles:
![]() |
T. Tanei, K. Morimoto, K. Shimazu, S. J. Kim, Y. Tanji, T. Taguchi, Y. Tamaki, and S. Noguchi Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers Clin. Cancer Res., June 15, 2009; 15(12): 4234 - 4241. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Emmenegger and R. J. Wechsler-Reya Stem Cells and the Origin and Propagation of Brain Tumors J Child Neurol, October 1, 2008; 23(10): 1172 - 1178. [Abstract] [PDF] |
||||
![]() |
G. J. Strewler Cancer Stem Cells and Bone Metastasis IBMS BoneKEy, September 1, 2008; 5(9): 308 - 322. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |